SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-148090
Filing Date
2024-05-28
Accepted
2024-05-28 16:06:33
Documents
14
Period of Report
2024-05-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d767413d8k.htm   iXBRL 8-K 40582
2 EX-3.1 d767413dex31.htm EX-3.1 130270
  Complete submission text file 0001193125-24-148090.txt   329701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vinc-20240522.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20240522_lab.xml EX-101.LAB 19483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20240522_pre.xml EX-101.PRE 12146
17 EXTRACTED XBRL INSTANCE DOCUMENT d767413d8k_htm.xml XML 3974
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 24991778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)